Continued value growth
|
|
- Vernon Underwood
- 5 years ago
- Views:
Transcription
1 Continued value growth Leendert Staal CEO & President DSM Nutritional Products Capital Markets Days 2012
2 Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this presentation, unless required by law. The English language version of this document is leading. A more comprehensive discussion of the risk factors affecting DSM s business can be found in the company s latest Annual Report, which can be found on the company's corporate website,
3 Overview Nutrition: continued value growth Program of today
4 Continued value growth in Nutrition Strong growth has been realized both organically and through 1.8bn in acquisitions in Kaiseraugst Including Ocean Nutrition Canada and Tortuga the Nutrition cluster will have: 4.4bn revenue with 20-23% EBITDA 10,000 people Sisseln Extended portfolio Increased global presence Extended value chain positions
5 Nutrition: strong increase in revenues and profit
6 Addressing fundamental needs Human Nutrition Animal Nutrition Health, wellness, longevity & healthy ageing through healthy nutrition. Efficient animal & marine protein production: feed conversion, growth, health & low mortality, lactation, fertility, minimize impact on the environment Personal care Protection and nourishment of skin and hair, slow-down & reversal of visible ageing, for wellness & positive selfawareness
7 Differentiation through Values and Scale Personal Care Human Nutrition Animal Nutrition Values Addressing real nutritional & health needs Building on science, technology and clinical evidence Delivering with utmost commitment to quality management Living sustainability Scale Presence, portfolio and people History, deep institutional know-how and broad IP Customers and partnerships Revenue > 4bn
8 Value creation and differentiation Active ingredients Delivery Systems Premix & Blends Broad product portfolio Vitamins One hundred ingredients Carotenoids Enzymes Nutritional Lipids Nutritional ingredients Personal care ingredients Several thousand forms Stability / Shelf Life Delivery / Solubility Bio-availability Powder / Flow Properties Tens of thousands of recipes Custom Formulation Dilution 3 rd party ingredients Quality, Reliability, Traceability, Sustainability Full Value Chain Player
9 Value chain: estimated incremental EBITDA Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services Estimated incremental EBITDA per step in the value chain (*) 12% 4% 4-8% 2-8% 2-6% Vitamins Carotenoids Enzymes Eubiotics Nutritional Lipids DCP Metal Chelates Amino acids Microencapsulates Beadlets Emulsions Adsorbates Vitamin concentrates Full premixes Complete feed Specialty feed: young animals milk Supplements Formulated products Human Health & well being Nutrient & feed composition Growth Disease prevention Fertility Estimated industry averages, for illustration purposes only
10 Our growth drivers Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services Estimated incremental EBITDA per step in the value chain (*) 12% 4% 4-8% 2-8% 2-6% Expand portfolio 1. Innovation 2. M&A 3. Partnership Cost management Improve ecofootprint Continuous differentiation: 1. Innovation 2. Application M&A Expand global footprint: 1. build 2. M&A Fit for market: 1. modular plants 2. Pharma, INF, DS, F&B Expand offering 1. focus on specialties 2. Create adjacencies M&A Nutritional science & advocacy Animal Nutrition Application Centers B2F M&A Estimated industry averages, for illustration purposes only
11 Positioning of typical industry players Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services DSM Tortuga Microbia Vitatene Martek ONC BASF Chinese VC players NHU, ZMC Chinese VB Lonza Fatrom Fortitech Cargill Provimi Nutreco De Heus Cilpaz
12 Rationale for recent acquisitions Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services DSM Tortuga Martek ONC
13 Nutritional Lipids: A new DSM growth platform DSM Nutritional Lipids, market leader in PUFAs Double digit growth business Sales ~ 500m* EBITDA > 145m* Omega-3 (DHA) and Omega-6 (ARA), algal derived Omega-3 (EPA/DHA), fish derived *including i-health
14 Tortuga, leader in supplements for ruminants Highly attractive business with excellent strategic fit Total enterprise value ~ 465m (*) in cash 2012 expectations: Sales ~ 385m, EBITDA ~ 60m Market leader in nutritional supplements with focus on pasture raised beef and dairy cattle Integrated production of key active ingredients, including organic trace minerals Strong technology, application and performance know-how Pecém São Paulo Mairinque São Vincente HQ Production *: Depending on the actual 2012 EBITDA, an adjustment in the purchase price up to a maximum enterprise value of ~ 490 million can be made, based on the same EBITDA-multiple
15 Rationale for recent acquisitions Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services DSM Martek ONC Leveraging the value chain
16 Rationale for recent acquisitions Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services DSM Martek ONC Leveraging global footprint
17 Rationale for recent acquisitions Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services DSM Tortuga Leveraging the value chain
18 Rationale for recent acquisitions Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services DSM Tortuga Leveraging global footprint
19 Recent acquisitions: new growth drivers Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services DSM Tortuga Martek ONC Leveraging the value chain Leveraging global footprint
20 Continued value growth: in conclusion Active ingredients Forms & delivery systems Premix Macro blends Nutritional consultancy & services Aspiration by 2015 Growth in ingredients & infrastructure Growth GDP + 2% EBITDA margin > 20-23% Strategy Continuous cost improvement Selectively broaden portfolio (innovation, M&A, partnership Differentiation through delivery technology Selective acquisitions which broaden/ enhance DSM s capabilities AND can leverage DSM s unique infrastructure / market access Production facilities Premix facility Main sales offices
21 Overview Continued value growth Program of today
22 Program of today 8.15 DSM Nutritional Products - Introduction Leendert Staal 8.35 Human Nutrition & Health (HNH) Rick Greubel 9.05 Nutritional Sciences HNH Manfred Eggersdorfer 9.25 Personal Care PC Ilona Haaijer 9.50 Animal Nutrition & Health ANH Antonio Ruy Freire Nutritional Sciences ANH Gilbert Weber Break Q&A session Transfer to Sisseln Site introduction + Lunch buffet Rene Vroege Visit to Vitamin E plant and Forms plant (small groups) End of conference
23 Contact: DSM Investor Relations P.O. Box 6500, 6401 JH Heerlen, The Netherlands (+31) internet: visiting address: Het Overloon 1, Heerlen, The Netherlands
The acquisition of Fortitech
The acquisition of Fortitech Accelerating DSM s strategy to become a full solutions provider in food ingredient blends Investor Relations 8 November 2012 Overview Fortitech at a glance Acquisition rationale
More informationNutrition Chris Goppelsroeder President & CEO DSM Nutritional Products ROYAL DSM HEALTH NUTRITION MATERIALS
Nutrition Chris Goppelsroeder President & CEO DSM Nutritional Products ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to
More informationHuman Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS
Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s
More informationDSM Capital Markets Day 2018
DSM Capital Markets Day 2018 Human Nutrition & Health Jeremy Xu President Human Nutrition & Health ROYAL DSM CAPITAL MARKETS DAY LONDON (UK) 20 JUNE 2018 Safe harbor statement This presentation may contain
More informationValue growth in Human Nutrition & Health
Value growth in Human Nutrition & Health Rick Greubel President Human Nutrition & Health US Field Trip September 4, 2014 Safe harbor statement This presentation may contain forward-looking statements with
More informationDriving Profitable Growth
Driving Profitable Growth through science-based, sustainable solutions Feike Sijbesma, CEO Royal DSM CONSUMER ANALYST GROUP EUROPE, London 22 March 2016 ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor
More informationContinued value growth in Nutrition
Stephan Tanda, Member of the Managing Board Continued value growth in Nutrition DSM Capital Markets Day 2013 Page Overview Delivering on strategy Update on integration & synergies acquisitions Strategy
More informationADM to Acquire Neovia and Probiotics International Limited. July 2, 2018
ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates
More informationFood Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS
Food Specialties Patrick Niels President DSM Food Specialties ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s future
More informationBALCHEM CORPORATION. Q Investor Relations Presentation
BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life
More informationHarm de Wildt MD TNI
Harm de Wildt MD TNI Nutreco Capital Markets Day Derbyshire, UK 17 September 1 2013 Agenda 1 2 3 Market overview Animal Nutrition Europe Animal Nutrition strategic priorities Application Solution Centres
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationInvestor Presentation
Investor Presentation Forward Looking Statements The information presented herein may contain projections, predictions, estimates and other forwardlooking statements within the meaning of Section 27A of
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationBalchem Corporation Investor Relations
Balchem Corporation Investor Relations May 2017 Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life on the planet.
More informationFood & Beverages Food for a growing world
Food & Beverages Food for a growing world Rasmus von Gottberg, Vice President F&B Marketing, Novozymes Christel Thea Jørgensen, Vice President R&D, Novozymes Jeremy Bentham, Go to Market Director, Cargill
More informationDuPont Nutrition & Health Craig Binetti, President
Craig Binetti, President Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this
More informationFor personal use only
ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting
More informationN a s d a q : I N S Y
N a s d a q : I N S Y 0 Safe Harbor Statement This presentation contains both historical information and forward-looking statements. Forward-looking statements are based on management's current expectations
More informationDelivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental
Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers
More informationConnect with consumers for life. Introducing new MEG-3 Ultra and life sdha Ultra
Connect with consumers for life Introducing new MEG-3 Ultra and life sdha Ultra ega-3s are essential for everyone, every day Omega-3 fatty acids play a critical role in supporting human health across different
More informationInvestor Day Lausanne, September 29, Nicholas Rolli Vice President, Investor Relations & Financial Communications
Investor Day Lausanne, September 29, 2016 Nicholas Rolli Vice President, Investor Relations & Financial Communications PMI Investor Relations Mobile Application ("App") / Wi-Fi Access Free app available
More informationDETERMINATION OF MERGER NOTIFICATION M/12/023 -
DETERMINATION OF MERGER NOTIFICATION M/12/023 - DSM/Fortitech Section 21 of the Competition Act 2002 Proposed acquisition by Royal DSM N.V. of sole control of Fortitech, Inc Dated 14 December 2012 Introduction
More informationADM to Acquire WILD Flavors
ADM to Acquire WILD Flavors Creating a Leading Global Flavors and Specialty-Ingredients Business July 7, 2014 ARCHER DANIELS MIDLAND COMPANY 1 Safe Harbor Statement Some of our statements constitute forward-looking
More informationPutting ALK on the right growth trajectory
Putting ALK on the right growth trajectory Økonomisk Ugebrevs Kapitalmarkedseftermiddag 15. marts 2018 Per Plotnikof, VP Corporate Communications and IR Marts 2018 Allergy: a global disease with a large
More informationGELATIN & AKIOLIS. Because every bio-molecule counts. Pol Deturck EVP Chemicals & Organic Specialties
GELATIN & AKIOLIS Because every bio-molecule counts Pol Deturck EVP Chemicals & Organic Specialties Why our bioplatform is promising Dual service provider and highly reliable partner Akiolis, the 3 rd
More informationAcasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2019 Planned Enrollment targets achieved in both TRILOGY studies with over 74% of patients randomized at more than 150 clinical sites
More informationNutritional Products & Wellness Solutions. Your Source of Excellence
Nutritional Products & Wellness Solutions Your Source of Excellence Company Neptune was founded in 1998 and pioneered the krill oil industry with the launch of our flagship product, Neptune Krill Oil
More informationA world leader in allergy immunotherapy
A world leader in allergy immunotherapy Investor Relations presentation June 2017 1 I Investor Relations presentation I June 2017 ALK: Towards redefining treatment of severe allergies The commercial leader
More informationOpportunities for Irish Dairy. An Industry Perspective
Opportunities for Irish Dairy An Industry Perspective Content 1 2 3 Who we are and what we do Kerry s approach to value creation Responding to opportunities: Recent market innovations 2 Taste & Nutrition
More informationOPPORTUNITIES FOR OMEGA-3 PRODUCTS
OPPORTUNITIES FOR OMEGA-3 PRODUCTS Prepared by: CPL Business Consultants The Manor House, Howbery Park, Wallingford, Oxfordshire, OX10 8BA Tel: +44 1491 822 844, info@cplconsult.com, www.cplconsult.com
More informationNUTRACEUTICALS: GLOBAL MARKETS
NUTRACEUTICALS: GLOBAL MARKETS FOD013E November 2014 Natraj Pandal Project Analyst ISBN: 1-56965-992-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within the
More informationNestlé Investor Seminar 2008
Nestlé Investor Seminar 2008 Nestlé Nutrition update on Acquisitions Richard Laube CEO Nestlé Nutrition 1 Disclaimer This presentation contains forward looking statements which reflect Management s current
More informationGenomic Health. Kim Popovits, Chairman, CEO and President
Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and
More informationSlide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO
Slide 1 Lars Rebien Sørensen President & CEO Slide 2 Capital Markets Day 2015 Slide 3 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission
More informationWhen the question is genetics, the answer is Invitae Invitae Corporation. All Rights Reserved. 1
When the question is genetics, the answer is Invitae. L A D E N B U R G T H A L M A N N 2 0 1 8 H E A LT H C A R E C O N F E R E N C E S E A N G E O R G E, C H I E F E X E C U T I V E O F F I C E R 2018
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationInvestor Presentation
Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities
More informationA GLOBAL LEADER IN PERSONALIZED NUTRITION
A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking
More informationClosing of Nucletron acquisition Building a stronger position in the cancer care market. September 15, 2011
Closing of Nucletron acquisition Building a stronger position in the cancer care market September 15, 2011 Important step in Elekta s growth strategy Nucletron is the world leader in Brachytherapy and
More informationSlide 1. Welcome and strategy update. Lars Fruergaard Jørgensen President and CEO
Slide 1 Lars Fruergaard Jørgensen President and CEO Slide 2 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission (SEC), including the company
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.
More informationTHE NATIONAL ACADEMIES
THE NATIONAL ACADEMIES NATIONAL ACADEMY OF SCIENCES INSTITUTE OF MEDICINE NATIONAL ACADEMY OF ENGINEERING NATIONAL RESEARCH COUNCIL DIVISION ON EARTH AND LIFE STUDIES BOARD ON AGRICULTURE AND NATURAL RESOURCES
More informationOUR VISION OUR OUTLOOK OUR COMMITMENT
OUR VISION OUR OUTLOOK Univar has been a part of the feed market nutrient sector since 1960 and we are excited by the vitality of our newly renamed division FeedNutrients. At Univar, our corporate vision
More informationCompany presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018
Company presentation SEB Nordic Seminar Bella Sky, Copenhagen Carsten Hellmann, President & CEO 9 January 2018 Allergy: a global disease with a large unmet need >500 million people affected by allergic
More informationHealth & Nutrition Driving Grains Innovation Australian Grains Industry Conference 29 July 2014
Health & Nutrition Driving Grains Innovation 2014 Australian Grains Industry Conference 29 July 2014 GLNC Overview GLNC Overview Independent authority on the nutrition and health benefits of grains and
More informationWelcome to the Full -Year Results Press Conference
Welcome to the Full -Year Results Press Conference Disclamer This presentation contains forward looking statements which reflect Management s current views and estimates. The forward looking statements
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More informationDr. Manfred Eggersdorfer Senior Vice President Research & Development DSM Nutritional Products
INTERNATIONAL CONFERENCE ON CSR AND COMBATING MALNUTRITION: OBTAINING MILLENNIUM DEVELOPMENT GOALS (MDGs) IN INDONESIA Keynote Address Dr. Manfred Eggersdorfer Senior Vice President Research & Development
More informationImplications of Ingredient Availability Opportunities for Vegetable Protein Meals
Implications of Ingredient Availability Opportunities for Vegetable Protein Meals John Spragg JCS Solutions FEED MANUFACTURE Grain Veg. Protein Meals Pig Poultry Animal Proteins Fats/Oils Vitamins Minerals
More informationConsumer Wellness in India Growth Ahead
1 Consumer Wellness in India Growth Ahead Indian Health & Wellness industry Valued at over INR 590 bn, growing at CAGR of 18% - 20% p.a. Growth expected to continue. Industry growth being driven by: Increasing
More informationGlobal Chymosin Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Chymosin Market Research Report 2016 Global Chymosin Market Research Report 2016 Publication ID: QYR101602046
More informationStraumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America
Media release Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Group net revenue rises 2% (l.c.) as double-digit increases across America offset
More informationBlood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595
Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample
More informationA short introduction to DSM (2017) The global science-based company active in health, nutrition and materials
A short introduction to DSM (2017) The global science-based company active in health, nutrition and materials Mission Our purpose is to create brighter lives for people today and generations to come We
More informationWilliam Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations
William Demant Jefferies Healthcare Conf. Nov. 2017 Søren B. Andersson, VP Investor Relations Agenda General update Key take-aways from November Interim Statement Hearing Devices Outlook 2017 Q&A 2 General
More informationWalgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs
Walgreen Co. Reports Second Quarter 2010 Earnings Per Diluted Share of 68 Cents; Results Include 2 Cents Per Diluted Share of Restructuring Costs Second quarter sales up 3.1 percent to record $17.0 billion
More informationMYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders
December 14, 2018 MYOS RENS Technology CEO Joseph Mannello Issues Letter to Shareholders CEDAR KNOLLS, N.J., Dec. 14, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS),
More informationValue creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO
Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Coloplast has four business areas all with global sales presence Group revenue
More informationMiFOOD2017. Grand Rapids April 18 th Daragh Maccabee SVP Procurement & Dairy Economics Glanbia Nutritionals
MiFOOD2017 Grand Rapids April 18 th 2017 Daragh Maccabee SVP Procurement & Dairy Economics Glanbia Nutritionals OUR BUSINESSES TODAY MARKET CAP 5BN EMPLOYEES 6,200 GLANBIA PERFORMANCE NUTRITION GLANBIA
More informationThe Complete Program Provides:
CATALOG Pharmace is a suite of solutions dedicated exclusively to helping independent community pharmacies. Each program provides professionally created promotional resources and proven-effective nutritional
More informationHARNESSING THE POWER OF ALGAE. for Human and Animal Nutrition
HARNESSING THE POWER OF ALGAE for Human and Animal Nutrition MARCEL WUBBOLTS, CTO CORBION 7/14/2018 Corbion: Who we are today 2 Key figures KEY FIGURES (2017) NET SALES BY REGION (2017) NET SALES 891.7mln
More informationAddressing key challenges of global growth with nutrition
DSM Capital Market Days Media Program Addressing key challenges of global growth with nutrition Stephan Tanda Basel, 27 September 2012 From 7 billion to 9 billion Page 2 Resource-constrained world Scarcity
More informationThe Diploma in Ruminant Nutrition
Further Information on the Modules that Make Up The Diploma in Ruminant Nutrition Taken from the Module Descriptors Ruminant Animal Production and the Feed Industry A4057 Academic Level 4 Rationale and
More informationContinuing the momentum to deliver improved performance. Robert Cascella Chief Business Leader Diagnosis & Treatment
Continuing the momentum to deliver improved performance Robert Cascella Chief Business Leader Diagnosis & Treatment Key takeaways Diagnosis & Treatment strategy is aligned with the Quadruple Aim Gaining
More information27 th Annual J.P. Morgan Healthcare Conference. January 13, 2009
27 th Annual J.P. Morgan Healthcare Conference January 13, 2009 1 Forward Looking Statements This presentation and any subsequent Q&A may contain forward-looking statements, including with respect to:»
More informationMedSurg: Endoscopy Presentation for the Investment Community at DDW. Art Butcher Senior Vice President and President, Endoscopy
MedSurg: Endoscopy Presentation for the Investment Community at DDW Art Butcher Senior Vice President and President, Endoscopy Safe Harbor for Forward-Looking Statements This presentation contains forward-looking
More informationAcorda Acquisition of Civitas Therapeutics. September 24, 2014
Acorda Acquisition of Civitas Therapeutics September 24, 2014 Forward Looking Statement This presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform
More informationIntercell and Novartis form world leading strategic partnership to drive vaccines innovation
Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell
More informationERNÆRING TIL JORDENS FATTIGSTE
ERNÆRING TIL JORDENS FATTIGSTE GAIN NORDIC PARTNERSHIP Charlotte Sørensen, Affordable food manager ARLA FOODS INGREDIENTS Process whey (by-stream from cheese production) into nutritious food ingredients
More informationThe world of Vitamins
The world of Vitamins A presentation by Steve Watts 8 th September 2014 What are Vitamins? Any of a group of organic compounds which are essential for normal growth and nutrition and are required in small
More informationCPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018
CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm
More informationAstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance. Becoming Global Leaders In Diabetes
AstraZeneca to Acquire Bristol- Myers Squibb Share of Global Diabetes Alliance Becoming Global Leaders In Diabetes 19th December 2013 Cautionary Statement Regarding Forward-Looking Statements In order,
More informationGlobal Vitamin Market Professional Survey Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Vitamin Market Professional Survey Report 2016 Global Vitamin Market Professional Survey Report 2016 Publication
More informationBoth news releases were disseminated through Stockwatch. The May 30, 2016, news release was also disseminated through Accesswire.
51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Laguna Blends Inc. (the Company ) #302-1912 Enterprise Way Kelowna, BC V1Y 9S9 Item 2 Date of Material Change May 19, 2016 and May 30,
More informationOur proposal relies in the development and implementation of effective technology innovations in the world of Omega 3 fatty acids.
BEST QUALITY Our state-of-the-art facility, strategic location and strong R&D orientation allow us to take the purity and quality of our Omega 3 concentrates to the next level. APPLIED INNOVATION Our proposal
More informationExpert support to create cost-effective dairy taste and texture
Milk Fat Replacers Expert support to create cost-effective dairy taste and texture With the growing trend for healthier food, more and more consumers are looking for lower trans fat options, dairy-free
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference Shire plc January 10, 2012 Angus Russell Chief Executive Officer Our purpose We enable people with life-altering conditions to lead better lives. THE SAFE HARBOR STATEMENT
More informationEPA DHA HARNESSING NATURE. ENABLING GROWTH.
EPA DHA HARNESSING NATURE. ENABLING GROWTH. Producing omega-3 fatty acids EPA and DHA from natural marine algae for animal nutrition One of nature s many treasures algae can be found in the sea. Natural
More informationSession Overview. Session Objectives. Location of Information on Labels. What is required on all labels? 5/21/2013
Making Special Claims On the Label and Off Megan L. Bruch Marketing Specialist Agencies involved in labeling Label requirements USDA FSIS requirements General Approval Special Claims and Approval Session
More informationDesigning a Smoke-Free Future
Designing a Smoke-Free Future Morgan Stanley Global Consumer & Retail Conference New York, November 14, 2017 Jacek Olczak Chief Financial Officer Martin King President, Asia Region Forward-Looking and
More informationValue creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO
Value creation through profitable growth Danske Bank Winter Seminar 2017, Copenhagen Lars Rasmussen, President & CEO Forward-looking statements The forward-looking statements contained in this presentation,
More informationST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015
ST. JUDE MEDICAL / THORATEC TRANSACTION HIGHLIGHTS July 22, 2015 1 FORWARD LOOKING STATEMENT This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More information4.2. DSM, having acquired Martek, is now the world s leading manufacturer of microbiallyproduced
4.1 4.2 DSM, having acquired Martek, is now the world s leading manufacturer of microbiallyproduced DHA and ARA. DHA and ARA are two fatty acids that are important for proper infant nutrition due to their
More informationH. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports
More informationINTRODUCTORY TRAINING
INTRODUCTORY TRAINING Who is BioCeuticals & Why range them? BioCeuticals is Australian Owned and is a leading provider of nutritional and therapeutic supplements Renowned for manufacturing and delivering
More informationTABLE of CONTENTS. What is Holding Our Animals Back?...5. Adding Value to Genetics with Nutrition...5. Blueprint Nutrition Program...
NUTRITION PROGRAM 1 2 NUTRITION PROGRAM TABLE of CONTENTS What is Holding Our Animals Back?...5 Adding Value to Genetics with Nutrition...5 Blueprint Nutrition Program...6 Building the Fundamentals of
More informationCowen Healthcare Conference
Cowen Healthcare Conference Shire plc March 9, 2010 Michael Cola President, Specialty Pharmaceuticals Our purpose We enable people with life-altering conditions to lead better lives 1 THE SAFE HARBOR STATEMENT
More informationMyriad Genetics Corporate Presentation 06/13/2018
Myriad Genetics Corporate Presentation 06/13/2018 Copyright 2016 2018 Myriad Genetics, Inc., all rights reserved. www.myriad.com. 1 Forward Looking Statements Some of the information presented here today
More informationFully Employed MBA (MGMT FE)
Fully Employed MBA (MGMT FE) 1 Fully Employed MBA (MGMT FE) Courses MGMT FE 200. Responding to Dynamic Times: Thinking Strategically in Organizations. 6 Units. Focuses on the strategic and organizational
More informationThe Global Alliance for Improved Nutrition
The Global Alliance for Improved Nutrition JCIE Seminar on Challenges in Global Health: New Opportunities for the Private Sector 27 July 2010, Tokyo 1 Outline Why Nutrition Matters About GAIN GAIN Nutrition
More informationCOMPANY PROFILE. AL SHAMS Group
COMPANY PROFILE AL SHAMS Group Al Shams Pharma Scintific Bureau Shams Al-Ibdaa Drug Store Bilim Pharma Co. Al-Shams Drug Store Al-Murjan Drug Store Al-Aqsa Pharmacy & Cosmetic Al-Khadraa Pharmacy & Cosmetic
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationIncrease in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014
Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) ( ) H1 2014 revenues and results - 24 July 2014 Forward-looking statement This presentation contains
More informationAXIM Biotechnologies Reports Year End 2017 Results
March 19, 2018 AXIM Biotechnologies Reports Year End 2017 Results NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research
More informationMedia Contact: Ron Rogers Investor Contact: Scott Gleason (801) (801)
News Release Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) 584-3065 (801) 584-1143 rrogers@myriad.com sgleason@myriad.com Myriad Receives FDA Approval of BRACAnalysis CDx as Companion
More informationALLERGAN TO ACQUIRE ZELTIQ FOR $2.47B BEST-IN-CLASS COMPANY IN FAST GROWING BODY CONTOURING SEGMENT
ALLERGAN TO ACQUIRE ZELTIQ FOR $2.47B BEST-IN-CLASS COMPANY IN FAST GROWING BODY CONTOURING SEGMENT ALLERGAN CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Statements contained in this presentation
More information2015 Investor Conference
2015 Investor Conference ACCELERATING PROFITABLE GROWTH Jill Schaaf President, Renal Care Teeramanas Tanaekakarapong, ESRD Patient, Bangkok, Thailand Becoming The Global Leader In Renal Care Our Global
More informationTRANSFORMATIONS IN THE FOOD INDUSTRY: REDUCING TRANS FAT IN THE DIET. Robert M. Reeves, President Institute of Shortening and Edible Oils
Agricultural Outlook Forum 2005 Presented Thursday, February 24, 2005 TRANSFORMATIONS IN THE FOOD INDUSTRY: REDUCING TRANS FAT IN THE DIET Robert M. Reeves, President Institute of Shortening and Edible
More informationLITTLE TREASURE. Premium Australian Made Powdered Milk Products
LITTLE TREASURE Premium Australian Made Powdered Milk Products Little Treasure Infant Formula and other Milk Powder products. Made in Australia to the highest possible standard, using milk from Australian
More information